Daily Report: 01/15/2024
A total of 8 studies were identified. These included 5 Phase 3 studies, 2 Phase 2 studies, and 1 Phase 1 study. Specifically, we located:
Endocrinology
One study in Type 2 Diabetes Management.
A phase 3 randomized, double-blind, active and placebo-controlled study investigated the effect of prusogliptin (DBPR108) in patients with newly diagnosed type 2 diabetes... [Read More]
Gastroenterology
One study in Gastritis.
A Phase 3 Randomized, Double-Blind, Noninferiority, Multicenter study investigated the effect of low-dose PPI (DW1903) and H2RA (DW1903R1) in patients with endoscopic erosive gastritis... [Read More]
Nephrology
One study in IgA Nephropathy.
A Phase 2 randomized controlled trial investigated the effect of Cemdisiran in patients with IgA nephropathy characterized by urine protein ≥1 g/24 hours... [Read More]
Oncology
Two studies in ALK-positive crizotinib-resistant NSCLC and Resectable Pancreatic Ductal Adenocarcinoma.
A phase I human radiolabeled mass balance study investigated the effect of iruplinalkib (WX-0593) in healthy subjects... [Read More]
A phase 2 randomized study investigated the effect of neoadjuvant FOLFIRINOX in patients with resectable pancreatic head cancer... [Read More]
One study in Advanced Neuroendocrine Tumors and Neuroendocrine Carcinomas
A Phase II Open-Label, Single-Arm, Multi-Cohort study investigated the effect of Surufatinib plus Toripalimab in patients with advanced NETs/NECs/MiNENs... [Read More]
Psychiatry
One study in Bipolar Mania.
A phase 3, randomized, double-blind, placebo-controlled study investigated the effect of iloperidone in patients with bipolar mania... [Read More]
Pulmonology
One study in Cough in Idiopathic Pulmonary Fibrosis.
The PACIFY COUGH study, a phase 2, multicentre, randomised, double-blind, placebo-controlled, two-way crossover trial investigated the effect of low dose controlled-release morphine in patients with idiopathic pulmonary fibrosis... [Read More]